單核苷酸多態性（SNP）基因型鑒定市場規模、佔有率和成長分析：按產品類型、技術平台、檢體矩陣、應用領域、最終用戶和地區分類－2026-2033年產業預測

2024 年全球單核苷酸多態性 (SNP)基因型鑒定市值為 366.4 億美元，預計到 2025 年將成長至 447.4 億美元，到 2033 年將成長至 2210 億美元，在預測期（2026-2033 年）內將成長到 2210 億美元，在預測期（2026-2033 年）內複合年成長率為 22.1%。

全球單核苷酸多態性 (SNP)基因型鑒定市場正經歷顯著成長，這主要得益於能夠識別 DNA 單鹼基變異的先進技術，這些技術在個人化醫療、先進農業和法醫學應用中發揮著至關重要的作用。該技術將遺傳標記與疾病易感性和治療反應等關鍵結果聯繫起來，從而影響臨床和農業策略。 SNP基因型鑒定方法的演變，從早期的 PCR 技術到尖端的次世代定序和 CRISPR 衍生技術，生動地展現了該市場的蓬勃發展。對精準醫療解決方案和生物標記主導藥物研發日益成長的需求，正在推動高通量、低成本平台的投資。這一趨勢正在催生高度擴充性的SNP 檢測組合，顯著降低檢體成本，並透過高效的遺傳資源篩檢加速農業的快速發展。

全球單核苷酸多態性（SNP）基因型鑒定市場促進因素

隨著個人化醫療的日益普及，對單核苷酸多態性（SNP）基因型鑒定的需求也急劇成長。這是因為醫療專業人員認知到，詳細的基因變異資訊對於有效選擇藥物和最佳化劑量至關重要。透過識別特定的單核苷酸突變，臨床醫生可以預測患者對治療的反應，最大限度地減少副作用，並改善整體治療效果。 SNP檢測的重要性促使醫療專業人員將其作為標準診斷工具，進而推動實驗室擴展服務範圍，並促使技術開發人員致力於提高檢測的靈敏度和處理能力。因此，SNP檢測在全球醫療保健領域實現了顯著成長。

全球單核苷酸多態性（SNP）基因型鑒定市場的限制因素

全球單核苷酸多態性（SNP）基因型鑒定市場面臨基因型鑒定平台高成本帶來的嚴峻挑戰。這一經濟障礙阻礙了SNP基因型鑒定的廣泛應用，尤其是在預算緊張的醫療環境中，資金往往優先用於基本服務而非先進的診斷工具。設備、耗材和專業人員所需的大量初始投資限制了其在小規模檢查室和新興市場的應用。因此，許多機構傾向於推遲將SNP基因型鑒定納入常規流程，轉而選擇更經濟實惠的替代方案，阻礙了市場滲透和成長潛力。此外，持續的維護和軟體更新成本也構成另一項挑戰，阻礙了注重預算的機構長期採用該技術。

全球單核苷酸多態性（SNP）基因型鑒定市場趨勢

全球單核苷酸多態性 (SNP)基因型鑒定市場正經歷一場變革，其特點是 SNP 分析與精準醫療方法的融合。隨著醫療服務提供者日益重視個人化治療方案，基於基因分型的風險評估也越來越受到重視，診斷公司和製藥公司之間的合作也日益加強。這種轉變推動了對經臨床檢驗、全面且高通量的 SNP 檢測組合的需求。供應商正積極響應這一趨勢，開發將基因資訊與電子健康記錄連結的整合數據平台，從而提升不同患者群體的可及性和效用，並促進其拓展至新的治療領域。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球單核苷酸多態性 (SNP)基因型鑒定市場規模：按產品類型分類

• 消耗品
  • 試劑
  • 檢測試劑盒
  • 基因型鑒定晶片
• 裝置
  • 序列器
  • 質譜儀
  • 微陣列掃描儀
• 軟體
• 服務
  • 專業服務
  • 託管服務

全球單核苷酸多態性 (SNP)基因型鑒定市場規模：按技術平台分類

• 聚合酵素鏈鎖反應
• 次世代定序
• 微陣列
• 基因晶片
• TaqMan等位基因辨識方法
• 單核苷酸多態性（SNP）焦磷酸測序
• SNPlex基因型鑒定系統
• Sekenom 質量陣列基質輔助雷射解吸/電離飛行時間(MATOF)

全球單核苷酸多態性（SNP）基因型鑒定市場規模：依檢體矩陣分類。

• 血液檢體
• 唾液拭子
• 頰黏膜細胞
• 植物組織樣本
• 動物組織樣本

全球單核苷酸多態性 (SNP)基因型鑒定市場規模：按應用向量分類

• 診斷研究
• 刑事鑑定
• 藥物基因體學學分析
• 農業生物技術
• 作物育種計劃
• 畜牧業最佳化

全球單核苷酸多態性（SNP）基因型鑒定市場規模：依最終用戶分類

• 學術研究機構
• 製藥公司
• 生物技術相關組織
• 診斷檢查室
• 法醫科學研究所
• 農業基因組學中心

全球單核苷酸多態性（SNP）基因型鑒定市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN NV
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Standard BioTools Inc.
• F. Hoffmann-La Roche Ltd
• LGC Biosearch Technologies
• Eurofins Scientific SE
• GenScript Biotech Corporation
• Takara Bio Inc.
• New England Biolabs Inc.
• Promega Corporation
• Integrated DNA Technologies Inc.
• PerkinElmer Inc.
• Macrogen Inc.
• BGI Group
• ArrayGen Technologies Pvt. Ltd.
• Novogene Co. Ltd.
• Genos

結論與建議

Global Single Nucleotide Polymorphism (SNP) Genotyping Market size was valued at USD 36.64 Billion in 2024 and is poised to grow from USD 44.74 Billion in 2025 to USD 221.00 Billion by 2033, growing at a CAGR of 22.1% during the forecast period (2026-2033).

The global single nucleotide polymorphism (SNP) genotyping market is experiencing significant growth driven by advanced technologies that identify single-base DNA changes, which play a crucial role in personalized healthcare, agricultural enhancements, and forensic applications. This capacity links genetic markers to critical outcomes such as disease predisposition and treatment responses, thereby shaping clinical and agricultural strategies. The evolution of SNP genotyping methods-from early PCR approaches to cutting-edge next-generation sequencing and CRISPR-inspired techniques-illustrates the dynamic nature of this market. Increasing demands for precision therapeutic solutions and biomarker-driven drug development are propelling investments in high-throughput, affordable platforms. This trend has led to the emergence of scalable SNP panels, reducing sample costs significantly and promoting rapid agricultural advancements through efficient germplasm screening.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Nucleotide Polymorphism (SNP) Genotyping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segments Analysis

Global single nucleotide polymorphism (SNP) genotyping market is segmented by product offering type, technology platform, sample specimen matrix, application vector, end user focus and region. Based on product offering type, the market is segmented into consumables, instruments, software and services. Based on technology platform, the market is segmented into polymerase chain reaction, next generation sequencing, microarrays, geneChips, TaqMan allelic discrimination, single nucleotide polymorphism pyrosequencing, SNPlex genotyping systems and Sequenom MassARRAY matrix-assisted laser desorption/ionization time-of-flight. Based on sample specimen matrix, the market is segmented into blood specimen, saliva swabs, buccal cells, plant tissue samples and animal tissue samples. Based on application vector, the market is segmented into diagnostic research, forensics testing, pharmacogenomics analysis, agricultural biotechnology, crop breeding programs and animal livestock optimization. Based on end user focus, the market is segmented into academic research institutes, pharmaceutical corporations, biotechnology establishments, diagnostic laboratories, forensic crime laboratories and agrigenomics centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Single Nucleotide Polymorphism (SNP) Genotyping Market

The growing focus on personalized medicine significantly boosts the demand for Single Nucleotide Polymorphism (SNP) genotyping, as healthcare providers recognize the necessity of detailed genetic variation information for effective drug selection and dosage optimization. By identifying specific single nucleotide variations, clinicians can anticipate patient responses to therapies, minimize adverse effects, and enhance overall treatment results. This importance of SNP testing prompts healthcare professionals to adopt it into standard diagnostic practices, leading laboratories to broaden their services and prompting technology developers to upgrade assay sensitivity and throughput, thus driving substantial growth within the global healthcare landscape.

Restraints in the Global Single Nucleotide Polymorphism (SNP) Genotyping Market

The Global Single Nucleotide Polymorphism (SNP) Genotyping market faces significant challenges due to the high costs associated with genotyping platforms. This financial barrier impedes widespread adoption, especially in resource-limited healthcare environments where funding often prioritizes essential services over advanced diagnostic tools. The considerable initial investment needed for equipment, consumables, and trained personnel limits access for smaller laboratories and emerging markets. As a result, many institutions may delay the incorporation of SNP genotyping into routine procedures, favoring more affordable alternatives, which hinders market penetration and growth potential. Additionally, ongoing expenses related to maintenance and software updates pose further challenges, dissuading long-term adoption by budget-conscious organizations.

Market Trends of the Global Single Nucleotide Polymorphism (SNP) Genotyping Market

The Global Single Nucleotide Polymorphism (SNP) Genotyping market is witnessing a transformative trend, characterized by the integration of SNP analysis into precision medicine approaches. As healthcare providers prioritize personalized treatment plans, the reliance on genotype-driven risk assessments is elevating the collaboration between diagnostic firms and pharmaceutical companies. This shift is leading to an increased demand for comprehensive, high-throughput SNP panels that are clinically validated. Vendors are responding by developing integrated data platforms that link genetic insights with electronic health records, enhancing accessibility and utility in diverse patient populations and expanding into new therapeutic domains.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Product Offering Type & CAGR (2026-2033)

• Market Overview
• Consumables
  • Reagents
  • Assay Kits
  • Genotyping Chips
• Instruments
  • Sequencers
  • Mass Spectrometers
  • Microarray Scanners
• Software
• Services
  • Professional Services
  • Managed Services

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Technology Platform & CAGR (2026-2033)

• Market Overview
• Polymerase Chain Reaction
• Next Generation Sequencing
• Microarrays
• GeneChips
• Taqman Allelic Discrimination
• Single Nucleotide Polymorphism Pyrosequencing
• SNPlex Genotyping Systems
• Sequenom MassARRAY Matrix-Assisted Laser Desorption/Ionization Time-of-Flight

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Sample Specimen Matrix & CAGR (2026-2033)

• Market Overview
• Blood Specimen
• Saliva Swabs
• Buccal Cells
• Plant Tissue Samples
• Animal Tissue Samples

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application Vector & CAGR (2026-2033)

• Market Overview
• Diagnostic Research
• Forensics Testing
• Pharmacogenomics Analysis
• Agricultural Biotechnology
• Crop Breeding Programs
• Animal Livestock Optimization

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by End User Focus & CAGR (2026-2033)

• Market Overview
• Academic Research Institutes
• Pharmaceutical Corporations
• Biotechnology Establishments
• Diagnostic Laboratories
• Forensic Crime Laboratories
• Agrigenomics Centers

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size & CAGR (2026-2033)

• North America (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • US
  • Canada
• Europe (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArrayGen Technologies Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations